Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer.
Christman
Karen L
KL
University of California Berkeley and San Francisco Joint Bioengineering Graduate Group, San Francisco, CA 94143, USA. karen@socrates.berkeley.edu
Fang
Qizhi
Q
Yee
Michael S
MS
Johnson
Kandice R
KR
Sievers
Richard E
RE
Lee
Randall J
RJ
D000818:Animals; D002352:Carrier Proteins / Q000008:administration & dosage* / Q000235:genetics; D016207:Cytokines / Q000008:administration & dosage* / Q000235:genetics; D004338:Drug Combinations; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage*; D018390:Gene Targeting / Q000379:methods; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D018919:Neovascularization, Physiologic / Q000187:drug effects* / Q000235:genetics; D010957:Plasmids / Q000008:administration & dosage*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016896:Treatment Outcome
D002352:Carrier Proteins; D016207:Cytokines; D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; C066845:pleiotrophin